期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | EXPERT OPINION ON THERAPEUTIC TARGETS LetPub Score 7.4
50 ratings
Rate
Reputation 8.8 Influence 6.4 Speed 7.0 | ||||||||||||||||||||||||||||
期刊簡稱 | EXPERT OPIN THER TAR | ||||||||||||||||||||||||||||
ISSN | 1472-8222 | ||||||||||||||||||||||||||||
E-ISSN | 1744-7631 | ||||||||||||||||||||||||||||
h-index | 78 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 2.20%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://www.tandfonline.com/loi/iett20#.V48c20z9cSQ | ||||||||||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/eott | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | Taylor and Francis Ltd. | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||
創刊年 | 2001 | ||||||||||||||||||||||||||||
每年文章數 | 93每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 13.79% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-8222%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Ordinary | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[EXPERT OPINION ON THERAPEUTIC TARGETS] 的評論 | 撰寫評論 |
作者: 大力欣然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-06-01 09:02:11 評論於 What kind of submission status have you all been through? Mine is still in Awaiting Commissioning Editor Processing(0) 讚! | 大力欣然 |
作者: 西域凡雁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-04 08:05:44 評論於 Hello, may I ask how long it took to receive it after the repair?(0) 讚! | 西域凡雁 |
作者: 墟散筠心 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-03 21:48:56 評論於 Review speed: 6.0 | Submission hit rate: 50.0 Emphasized research direction: Targeted nanoformulations Experience sharing: The review process is really slow, maybe it's an issue with my paper, it took 4 months to receive minor revision comments(0) 讚! | 墟散筠心 |
作者: 多罗易青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-04 12:05:18 評論於 Do you need to pay for the layout fee?(0) 讚! | 多罗易青 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:03:07 評論於 Thank you to the editors and reviewers; revisions have been made diligently, but experiments require time; confirming the time needed(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:26:54 評論於 Please write a letter to the editor requesting an extension(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 17:25:20 評論於 How to write a letter requesting an extension?(0) 讚! | Oswald Edie |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:51:40 評論於 How to apply for an extension?(0) 讚! | 深渊兴业 |
作者: 雅韵小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-10 23:57:20 評論於 Do you need to provide the original data?(0) 讚! | 雅韵小仙女 |
作者: 雷尔夫卡米拉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-08-12 23:39:03 評論於 The review process is slow, and every reminder for submission is perfunctory(0) 讚! | 雷尔夫卡米拉 |
作者: 东风谷东方 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-28 23:54:21 評論於 Submission acceptance rate: 25.0 Experience sharing: It is indeed very difficult, which refreshed my understanding of the speed of rejection. I submitted an article, and I received the acceptance and rejection emails at the same time. The time difference was only 4 minutes(0) 讚! | 东风谷东方 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 09:20:46 評論於 Hesitating, but staying at this critical point, pushing further up is not easy. With over 4 points, I can consider it satisfactory(0) 讚! | 凌霄高洁 |
作者: 中原谷枫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-04-15 16:04:10 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 50.0 Experience Sharing: It was extremely lucky that my article got accepted by this journal on the first try. The submission process and the journal's focus perfectly matched my research. After one round of revisions requiring the addition of siRNA to increase the persuasiveness of the article, the timeline was quite tight. I had to request an extension of the revision deadline. The editors were very nice, and once the article was accepted, it was published quickly. If time is not pressing, consider the Standard mode which doesn't require page fees. It's very cost-effective!(0) 讚! | 中原谷枫 |
作者: 仙灵涒滩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-05-13 19:42:52 評論於 I published an article 12 years ago, and now I am submitting another review article. I hope for good luck(0) 讚! | 仙灵涒滩 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-04-03 09:48:57 評論於 Hoping for IF>4 in 2012. I recently published an article in this journal, focusing primarily on some new effects of drugs in clinical trials. It was quite challenging. The publication cycle for my article is approximately 5 months(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us